Crisaborole API & I...

Crisaborole API & Intermediates

Crisaborole API & Intermediates

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: ≥99%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Crisaborole 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole Eucrisa

Quick Details

  • Appearance:
  • Application:Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving di
  • PackAge:Barrel sealed
  • ProductionCapacity:500|Kilogram|Day
  • Storage:
  • Transportation:

Superiority:

Our company has commercialized this product for long-term stable supply, the purity ≥ 99.5%. At present, our sales of this product have reached more than 670 kg

Details:

Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reducing the signs and symptoms in patients 2 years old and older. It reduces the local inflammation in the skin and prevents further exacerbation of the disease with a good safety profile. Its structure contains a boron atom, which facilitates skin penetration and binding to the bimetal center of the phosphodiesterase 4 enzyme. It is currently under development as topical treatment of psoriasis.

Conpany profile：
Office located in Hightech industrial development zone No. 8, Huangguan Road, Daguan District, Anqing, Anhui Province, 200 workers, more than 10 years experience, Exhibitors of CPhI China 2020, CE & FDA certificate is under the process, will finish in 1 year. Currently we have 16 cooperative companies in Southeast Asia.
Factory profile：
Located in Changzhi, Shanxi including 2500㎡ analysis laboratories equipped with HPLC, GC and other analytical facilities.
One pilot and two mass production workshop with more than 70 glass lined reactors, total reaction capacity can reach 35000L.
 
Latest main product：
Parecoxib sodium，Brivaracetam，Canagliflozin，Empagliflozin，Dapagliflozin，Tofacitinib，Pimavanserin，Crisaborole，Vonoprazan Fumarate，Tolvaptan ，Febuxostat，Brexpiprazole，Apixaban，Rivaroxaban，Eltrombopag，Ticagrelor，Avatrombopag，Baricitinib，Ruxolitinib，Upadacitinib，Dabigatran，Tavaborole，Finafloxacin Hydrochloride，Topiroxostat
（All products above can be sold in API and intermediates）
Provid：
  • MOA
  • ROS
  • COA
  • MSDS
  • GMP Standard
  • ISO9001:2008 Quality System Certification
 
Research and provide synthetic process services:
Brivaracetam, Riociguat, Urapidil, Urapidil, Norepinephrine, Empagliflozin, Baricitinib, Upadacitinib, Tavaborole, Finafloxacin, Crisaborole, Ruxolitinib
At the same time, we also provide a full set of services for testing and registering drugs apply to the China National FDA till you get the China National FDA certificate

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View